Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Paratek Pharma Inc (PRTK)

Paratek Pharma Inc (PRTK)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.23 +0.04 (+1.83%) 09/20/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.23 unch (unch) -
Quote Overview for Wed, Sep 20th, 2023
Day Low
2.19
Day High
2.24
Open 2.19
Previous Close 2.19 2.19
Volume 4,764,400 4,764,400
Avg Vol 987,575 987,575
Stochastic %K 41.11% 41.11%
Weighted Alpha +6.10 +6.10
5-Day Change +0.03 (+1.36%) +0.03 (+1.36%)
52-Week Range 1.29 - 3.65 1.29 - 3.65
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 127,828
  • Shares Outstanding, K 57,322
  • Annual Sales, $ 160,270 K
  • Annual Income, $ -63,570 K
  • EBIT $ -45 M
  • EBITDA $ -44 M
  • 60-Month Beta 1.70
  • Price/Sales 0.78
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.10
  • Most Recent Earnings $-0.25 on 08/03/23
  • Next Earnings Date 11/02/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.009 on 10/31/14
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.25
  • Number of Estimates 2
  • High Estimate -0.24
  • Low Estimate -0.25
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +34.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.17 +2.76%
on 08/21/23
Period Open: 2.21
2.24 -0.45%
on 09/20/23
+0.02 (+0.90%)
since 08/18/23
3-Month
2.17 +2.76%
on 08/21/23
Period Open: 2.19
2.24 -0.45%
on 09/20/23
+0.04 (+1.83%)
since 06/20/23
52-Week
1.29 +72.87%
on 03/16/23
Period Open: 2.40
3.65 -38.90%
on 11/01/22
-0.17 (-7.08%)
since 09/20/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, NEWR, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NEWR : 86.99 (+0.02%)
AEL : 56.47 (+0.55%)
PRTK : 2.23 (+1.83%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Paratek Pharmaceuticals, Inc. by Gurnet Point Capital

/PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Paratek Pharmaceuticals, Inc....

PRTK : 2.23 (+1.83%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRTN, AMED, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMED : 93.63 (+1.30%)
PRTK : 2.23 (+1.83%)
TRTN : 79.55 (-4.10%)
Paratek: Q2 Earnings Snapshot

Paratek: Q2 Earnings Snapshot

PRTK : 2.23 (+1.83%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRTK, PTEN, NEX, BG

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NEX : 10.61 (+0.95%)
BG : 79.82 (-0.34%)
PTEN : 5.88 (unch)
PRTK : 2.23 (+1.83%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Paratek Pharmaceuticals, Inc. by Gurnet Point Capital

/PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Paratek Pharmaceuticals, Inc....

PRTK : 2.23 (+1.83%)
NexPoint Sends Demand Letter for Books and Records to Paratek Pharmaceuticals in Connection with Proposed Acquisition by Gurnet Point Capital

/PRNewswire/ -- NexPoint Event Driven Fund today issued a demand letter to the Board of Directors of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) (the...

PRTK : 2.23 (+1.83%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, PTEN, NEX, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NEX : 10.61 (+0.95%)
NETI : 11.33 (+0.09%)
PTEN : 5.88 (unch)
PRTK : 2.23 (+1.83%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates WMC, SGTX, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WMC : 9.18 (+4.44%)
PRTK : 2.23 (+1.83%)
SGTX : 22.47 (-2.56%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates QUOT, PRTK, TESS, HMPT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TESS : 8.99 (+0.11%)
HMPT : 2.32 (unch)
PRTK : 2.23 (+1.83%)
QUOT : 3.99 (unch)

Business Summary

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapeutics that treat infectious disease agents. The Company's lead product candidate, omadacycline, is a tetracycline-derived antibiotic being developed for use...

See More

Key Turning Points

3rd Resistance Point 2.30
2nd Resistance Point 2.27
1st Resistance Point 2.25
Last Price 2.23
1st Support Level 2.20
2nd Support Level 2.17
3rd Support Level 2.15

See More

52-Week High 3.65
Fibonacci 61.8% 2.75
Fibonacci 50% 2.47
Last Price 2.23
Fibonacci 38.2% 2.19
52-Week Low 1.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective